Sep. 11, 2014

Leading Orgs Take to the Hill to Discuss Need to Accelerate New Medicines for Lupus & Other Diseases

Lupus Foundation of America and Rheumatology Research Foundation hold congressional briefing

Jul. 01, 2014

A New Generation of Researchers Enlisted in the Fight to Solve the ‘Cruel Mystery’

Lupus Foundation of America announces its 2014 National Lupus Research Program Summer Fellowships and Career Development Awards

Jun. 26, 2014

Dr. Bruce Richardson Receives Lupus Insight Prize Recognizing Outstanding Contribution in Research

Jun. 09, 2014

Bruce Richardson is Second Recipient of the Lupus Insight Prize

Dr. Richardson’s work has provided a strong foundation from which further advances in the understanding and treatment of lupus can be made.

Apr. 06, 2014

Lupus Foundation of America and BMJ Publish First Open Access Journal Dedicated To Lupus

The Lupus Foundation of America and BMJ recently announced the launch and publication of the first scientific research articles in Lupus Science & Medicine™.

Mar. 24, 2014

Announcing a New Initiative to Improve Health and Quality of Life

The Lupus Foundation of America is funding and leading the development of a first-of-its-kind tool to monitor lupus disease activity called the LFA-REAL™ (Rapid Evaluation of Activity in Lupus) System. LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential to greatly improve medical care and quality of life for people living with this unpredictable and misunderstood autoimmune disease.

Feb. 20, 2014

UNVEIL Your Experiences with Lupus

The Lupus Foundation of America, in partnership with Eli Lilly and Company and the research firm ICON plc, is conducting an online national research study to better understand the impact of lupus on people with the disease and their caregivers.

Feb. 06, 2014

NIH Announces Partnership to Accelerate Development of New Treatments for Lupus & Other Diseases

The Lupus Foundation of America will partner with the Foundation for the National Institutes of Health (FNIH) to support a new five-year initiative that will accelerate the ability to develop new medicines for lupus and other diverse and complex diseases.